connected inhaler

It follows the clearance for connecting Hailie with AstraZeneca's Symbicort inhaler.

The connected inhaler's launch will be followed by Teva's other Digihaler products before the end of the year.

While connected devices currently reign supreme, authors of the report see a market opportunity for new players offering a purely digital service.

Bensheim, Germany-based drug delivery system manufacturer Sanner GmbH and London, UK-based Amiko — a startup that has leveraged smart sensors and artificial intelligence to develop its connected inhaler and app suite Respiro — are looking to integrate novel technologies into medication packaging to better address the challenges of medication adherence.

New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first half of 2018 with a direct-to-consumer (and direct-to-payer) strategy.

London-based Amiko Digital Health, which makes connected inhaler and app suite Respiro, has raised a new round of funding.

Novartis has announced a partnership with Qualcomm Life, a subsidiary of Qualcomm, to develop a connected version of its inhaler, Breezhaler, for people who have COPD.

GSK's Ellipta inhaler GlaxoSmithKline and Madison, Wisconsin-based Propeller Health announced a partnership today in which Propeller will develop and manufacture a custom sensor for GSK's Ellipta inhaler for COPD patients.

Adherium, the Australian connected inhaler company that partnered with AstraZeneca earlier this summer, has released data from three small studies of the company's Smartinhaler system.

Adherium Limited, a New Zealand company working on a smart inhaler, has raised $25.